Pfizer’s acquisition of Wyeth appears to be paying off for the world’s largest drug maker....
Sanofi-Aventis has cleared its tender offer for Chattem with government antitrust officials, the French drug...
Daniel Vasella will step down as CEO of Novartis to focus on his position as...
Sandoz is “confident” that it will win approval for a generic anti-clotting drug, according to...
Teva Pharmaceutical Industries may soon get the green light to market a generic drug for...
Bayer Schering Pharma will halt a mid-stage clinical trial of an investigational treatment for hemophilia,...
A generic version of a gastroesophageal reflux disease drug that dissolves in the mouth doesn’t...
New York Gov. David Paterson hopes to put an end to gifts from drug companies...
Roche is investing 190 million Swiss francs (U.S. $182 million) into production of a new...
The Food and Drug Administration has given tentative approval to Teva Pharmaceutical Industries for its...
Alcon has seen Novartis’ acquisition offer, and it is not impressed....
Two drug companies are in a race to buy a German generic drug maker, according...
The chairman of the Federal Trade Commission and several members of Congress are calling for...
Moody’s Investors Service announced Wednesday that it had upgraded the ratings of generic drug maker...
Four drug companies have received warnings from the Food and Drug Administration in the last...
Prices of 416 branded drugs dramatically rose between 2000 and 2008, according to a recent...
Teva hopes to garner revenues of $31 billion and net income of $6.8 billion by...
A Belgian biotech company plans to work with Swiss drug maker Roche to develop treatments...
GlaxoSmithKline has obtained an exclusive license to develop and commercialize an investigational treatment for such...
If you’re a pharmaceutical manufacturer, wholesaler or retailer, that distinct chill you’ve been feeling at...
Novartis has launched a new drug for treating schizophrenia in the United States, the Swiss...
Sanofi-Aventis is the latest pharma powerhouse to make the move toward over-the-counter medicine with its...
Sanofi-Aventis on Monday announced the commencement of a tender offer through its wholly-owned subsidiary, River...
Zegerid OTC was approved for sale as a nonprescription remedy for frequent heartburn last month,...
A biopharmaceutical company announced the resignation of one of its executives....